Haemonetics

Q3 2026 Q2 2026 +31.77%Q1 2026 -26.83%Q4 2025 +5.87%Q3 2025 -11.58%Q2 2025 +11.85%Q1 2025 -10.14%Q4 2024 +2.80%Q3 2024 -3.77%Q2 2024 +2.36%Q1 2024 +2.01%Q4 2023 +7.64%Q3 2023 -5.45%Q2 2023 +4.12%Q1 2023 +8.11%Q4 2022 +3.90%Q3 2022 +21.18%Q2 2022 -13.52%Q1 2022 +8.38%Q4 2021 -6.40%Q3 2021 +12.84%Q2 2021 -3.72%Q1 2021 -12.72%Q4 2020 -8.80%Q3 2020 +7.19%Q2 2020 +0.29%Q1 2020 +10.52%Q4 2019 +2.81%Q3 2019 -12.16%Q2 2019 +9.14%Q1 2019 +4.80%Q4 2018 +5.81%Q3 2018 +14.84%Q2 2018 +15.78%Q1 2018 +4.20%Q4 2017 -1.90%Q3 2017 -10.14%Q2 2017 +10.48%Q1 2017 +13.79%Q4 2016 -15.05%Q3 2016 +5.88%Q2 2016 -3.93%Q1 2016 +1.45%Q4 2015 -3.94%Q3 2015 +7.03%Q2 2015 -5.91%Q1 2015 -1.36%Q4 2014 -7.97%Q3 2014 -2.60%Q2 2014 +1.52%Q1 2014 +0.72%Q4 2013 -1.40%Q3 2013 -5.63%Q2 2013 +4.26%Q1 2013 -0.10%Q4 2012 +4.16%Q3 2012 -1.02%Q2 2012 +0.44%Q1 2012 +3.06%Q4 2009 +1.33%Q4 2011 +1.33%Q3 2010 -1.29%Q3 2011 -1.29%Q2 2011 +1.70%Q1 2010 -2.53%Q1 2011 -2.53%Q2 2010 -2.53%Q4 2010 -2.53%

Aug 10, 2022

•

Jul 02, 2022

Haemonetics Q1 2023 Earnings Report

Previous year: -$15.6M

-77.7%

Total Assets

$1.82B

Previous year: $1.79B

+1.5%

Haemonetics

Unlock previous datapoints

Upgrade

Haemonetics

Unlock previous datapoints

Upgrade

Revenue by Segment

Plasma Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Blood Center Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Hospital Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Company Overview

Full financial data and analysis

View Haemonetics

Products

Get in Touch

Resources

Haemonetics

Haemonetics Q1 2023 Earnings Report

Haemonetics

Haemonetics

Revenue by Segment

Plasma Revenue

Blood Center Revenue

Hospital Revenue

Revenue & Expenses

Historical Earnings Impact

Avg. Return Before/After Earnings

Company Overview

Haemonetics Revenue by Segment